VANCOUVER, British Columbia, Sept. 11, 2017 -- DOSarrest Internet Security announced today that they have released their new DDoS protection software, along with a number of other advances and upgrades. This is DOSarrest’s 5th major release since starting in the fully managed cloud based DDoS protection service in 2007.
This latest release is a complete rewrite of DOSarrest’s front end and backend systems utilizing the latest software development tools and technologies.
Some of the new enhancements include.
- All new customer facing portal with 15 real-time, interactive traffic statistics displays.
- Complete new back end with new security features that can be deployed live in seconds
- All new big data analytics engine for faster real-time and historical statistics displays
- Machine learning module for traffic anomaly and bot detection
- All new larger routers and increased upstream capacity in all global locations
Mark Teolis, CEO at DOSarrest, explains, “We are in our 11th year of providing a fully managed cloud based DDoS protection service, and if there’s one thing we have learned it’s that you'd better be ahead of the bad actors. This new release was developed with extreme flexibility in mind; we can basically analyze and create a feature that will stop any sophisticated attacks not yet even seen in the wild.”
Teolis adds, “The biggest misconception in the DDoS protection world is that you only need capacity to fend off DDoS attacks, but in reality your chance of being hit by a small 10Mb/sec attack that will take your site down is millions of times greater.”
About DOSarrest Internet Security:
DOSarrest founded in 2007 in Vancouver, B.C., Canada is one of only a couple of companies worldwide to specialize in only cloud based DDoS protection services. Additional Web security services offered are Cloud based Web Application Firewall (WAF), Vulnerability Testing and Optimization (VTO), DataCenter Defender-GRE as well as cloud based global load balancing.
More information at www.DOSarrest.com
Media Contact: Julie Trudel
Toll free CAD/US 1-888-818-1344 ext. 208
UK Freephone 0800-016-3099 ext. 208
[email protected]


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



